
Clover Health (CLOV) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
462.3M
Gross Profit
108.9M
23.55%
Operating Income
-1.3M
-0.28%
Net Income
-1.3M
-0.28%
EPS (Diluted)
$0.00
Balance Sheet Metrics
Total Assets
583.7M
Total Liabilities
247.6M
Shareholders Equity
336.1M
Debt to Equity
0.74
Cash Flow Metrics
Operating Cash Flow
-24.3M
Free Cash Flow
-16.5M
Revenue & Profitability Trend
Clover Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.4B | 2.0B | 3.5B | 1.5B | 672.9M |
Cost of Goods Sold | 1.0B | 1.8B | 3.5B | 1.6B | 590.1M |
Gross Profit | 364.8M | 257.3M | 22.7M | -79.2M | 82.8M |
Gross Margin % | 26.6% | 12.7% | 0.7% | -5.4% | 12.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 408.9M | 444.7M | 486.6M | 445.7M | 192.1M |
Other Operating Expenses | - | -7.2M | -93.4M | 110.8M | -17.1M |
Total Operating Expenses | 408.9M | 437.5M | 393.2M | 556.6M | 175.0M |
Operating Income | -45.5M | -182.7M | -371.6M | -637.0M | -92.7M |
Operating Margin % | -3.3% | -9.0% | -10.7% | -43.3% | -13.8% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | 117.3K |
Interest Expense | 0 | 7.0K | 1.4M | 16.9M | 57.1M |
Other Non-Operating Income | -805.0K | -30.7M | 33.4M | 66.1M | 13.4M |
Pre-tax Income | -46.3M | -213.4M | -339.6M | -587.8M | -136.4M |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -43.0M | -213.4M | -339.6M | -587.8M | -136.4M |
Net Margin % | -3.1% | -10.5% | -9.8% | -39.9% | -20.3% |
Key Metrics | |||||
EBITDA | -44.1M | -180.2M | -370.5M | -635.7M | -92.2M |
EPS (Basic) | $-0.08 | $-0.44 | $-0.71 | $-1.25 | $-0.23 |
EPS (Diluted) | $-0.08 | $-0.44 | $-0.71 | $-1.25 | $-0.23 |
Basic Shares Outstanding | 490018730 | 482176127 | 476244262 | 470852394 | 404440809 |
Diluted Shares Outstanding | 490018730 | 482176127 | 476244262 | 470852394 | 404440809 |
Income Statement Trend
Clover Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 194.5M | 122.9M | 103.8M | 300.0M | 92.3M |
Short-term Investments | 27.0M | 119.8M | 231.0M | 315.3M | 4.4M |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | 15.6M | 1.4M | 4.0M | 2.5M | 299.0K |
Total Current Assets | 343.1M | 428.0M | 625.0M | 752.5M | 189.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | 113.0K | 3.5M | 4.3M | 5.5M | 8.0M |
Goodwill | 3.0M | 3.0M | 31.7M | 4.2M | 4.2M |
Intangible Assets | 3.0M | 3.0M | 8.3M | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 13.3M | 10.2M | 15.7M | 10.4M | 8.9M |
Total Non-Current Assets | 237.6M | 142.7M | 183.6M | 198.3M | 77.5M |
Total Assets | 580.7M | 570.7M | 808.6M | 950.8M | 267.3M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 34.6M | 37.2M | 32.4M | 28.1M | 30.7M |
Short-term Debt | - | 1.7M | 1.8M | 3.1M | 25.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 3.5M | 16.6M | 74.3M | 37.0M | 5.0K |
Total Current Liabilities | 213.5M | 261.1M | 431.5M | 372.6M | 164.2M |
Non-Current Liabilities | |||||
Long-term Debt | - | 3.0M | 4.0M | 24.8M | 112.8M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 26.1M | 20.2M | 16.2M | 14.1M | 13.1M |
Total Non-Current Liabilities | 26.1M | 23.2M | 20.2M | 38.9M | 716.2M |
Total Liabilities | 239.6M | 284.3M | 451.7M | 411.5M | 880.4M |
Equity | |||||
Common Stock | 50.0K | 49.0K | 46.0K | 46.0K | 9.0K |
Retained Earnings | -2.2B | -2.2B | -1.9B | -1.6B | -1.0B |
Treasury Stock | 31.0M | 12.7M | 6.5M | 147.0K | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 341.1M | 286.4M | 356.9M | 539.3M | -613.2M |
Key Metrics | |||||
Total Debt | 0 | 4.7M | 5.9M | 27.8M | 138.4M |
Working Capital | 129.6M | 166.9M | 193.5M | 379.9M | 25.6M |
Balance Sheet Composition
Clover Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -43.0M | -213.4M | -339.6M | -587.8M | -136.4M |
Depreciation & Amortization | 1.3M | 2.5M | 1.2M | 1.2M | 555.0K |
Stock-Based Compensation | 114.3M | 140.9M | 164.3M | 163.7M | 7.1M |
Working Capital Changes | 13.6M | 50.4M | -99.9M | 39.9M | -1.0M |
Operating Cash Flow | 83.1M | -23.6M | -275.4M | -368.9M | -80.5M |
Investing Activities | |||||
Capital Expenditures | -1.6M | -584.0K | -4.5M | -723.0K | -693.0K |
Acquisitions | 0 | 0 | -16.4M | 0 | 0 |
Investment Purchases | -201.2M | -175.6M | -369.4M | -876.3M | -174.3M |
Investment Sales | 203.4M | 316.2M | 485.4M | 441.5M | 312.4M |
Investing Cash Flow | 565.0K | 140.0M | 95.1M | -435.4M | -690.6M |
Financing Activities | |||||
Share Repurchases | -18.3M | -6.2M | -6.4M | -147.0K | -957.0K |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | 0 | 0 | 20.0M |
Debt Repayment | - | 0 | 0 | -30.9M | -18.8M |
Financing Cash Flow | -17.4M | -33.9M | 77.5M | 925.1M | 6.7M |
Free Cash Flow | 33.3M | -116.5M | -290.8M | -283.0M | -119.2M |
Net Change in Cash | 66.3M | 82.6M | -102.8M | 120.7M | -764.5M |
Cash Flow Trend
Clover Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-31.50
Forward P/E
-18.64
Price to Book
3.87
Price to Sales
0.83
PEG Ratio
0.10
Profitability Ratios
Profit Margin
-2.68%
Operating Margin
-2.21%
Return on Equity
-12.59%
Return on Assets
-4.26%
Financial Health
Current Ratio
1.80
Debt to Equity
0.00
Beta
1.92
Per Share Data
EPS (TTM)
$-0.08
Book Value per Share
$0.67
Revenue per Share
$3.21
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
clov | 1.3B | -31.50 | 3.87 | -12.59% | -2.68% | 0.00 |
UnitedHealth | 279.4B | 13.35 | 2.95 | 21.65% | 5.04% | 75.58 |
CVS Health | 87.0B | 19.11 | 1.12 | 5.88% | 1.18% | 106.67 |
Progyny | 2.0B | 38.54 | 3.77 | 10.94% | 4.28% | 5.56 |
Cigna | 79.2B | 16.28 | 1.97 | 13.18% | 1.92% | 76.10 |
Elevance Health | 70.8B | 13.35 | 1.62 | 12.42% | 2.83% | 68.84 |
Financial data is updated regularly. All figures are in the company's reporting currency.